Human T-cell leukemia virus type I-associated myelopathy following living-donor liver transplantation.
Soyama, Akihiko
Human T-cell leukemia virus type I-associated myelopathy following living-donor liver transplantation. [electronic resource] - Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society May 2008 - 647-50 p. digital
Publication Type: Case Reports; Journal Article
1527-6473
10.1002/lt.21414 doi
Antiviral Agents--therapeutic use
Drug Therapy, Combination
Gait Disorders, Neurologic--etiology
Graft Rejection--prevention & control
Hepatitis C--complications
Humans
Immunosuppressive Agents--therapeutic use
Interferon alpha-2
Interferon-alpha--therapeutic use
Liver Cirrhosis--surgery
Liver Transplantation--adverse effects
Living Donors
Male
Middle Aged
Paraparesis, Tropical Spastic--complications
Recombinant Proteins
Steroids--therapeutic use
Tacrolimus--therapeutic use
Treatment Outcome
Urination Disorders--etiology
Human T-cell leukemia virus type I-associated myelopathy following living-donor liver transplantation. [electronic resource] - Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society May 2008 - 647-50 p. digital
Publication Type: Case Reports; Journal Article
1527-6473
10.1002/lt.21414 doi
Antiviral Agents--therapeutic use
Drug Therapy, Combination
Gait Disorders, Neurologic--etiology
Graft Rejection--prevention & control
Hepatitis C--complications
Humans
Immunosuppressive Agents--therapeutic use
Interferon alpha-2
Interferon-alpha--therapeutic use
Liver Cirrhosis--surgery
Liver Transplantation--adverse effects
Living Donors
Male
Middle Aged
Paraparesis, Tropical Spastic--complications
Recombinant Proteins
Steroids--therapeutic use
Tacrolimus--therapeutic use
Treatment Outcome
Urination Disorders--etiology